Medical Developments International Limited (MVP.AX)
AUD 0.4
(-2.47%)
AUD 0.4
(-2.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 13.42 Million AUD | -52.34% |
| 2023 | 28.17 Million AUD | -36.06% |
| 2022 | 44.06 Million AUD | 38.24% |
| 2021 | 31.87 Million AUD | -38.13% |
| 2020 | 51.51 Million AUD | 28.1% |
| 2019 | 40.21 Million AUD | 41.06% |
| 2018 | 28.5 Million AUD | 41.38% |
| 2017 | 20.16 Million AUD | -9.23% |
| 2016 | 22.21 Million AUD | 298.03% |
| 2015 | 5.58 Million AUD | -17.15% |
| 2014 | 6.73 Million AUD | 48.04% |
| 2013 | 4.55 Million AUD | 53.35% |
| 2012 | 2.96 Million AUD | 31.4% |
| 2011 | 2.25 Million AUD | 50.23% |
| 2010 | 1.5 Million AUD | -4.75% |
| 2009 | 1.57 Million AUD | 13.69% |
| 2008 | 1.38 Million AUD | 26.87% |
| 2007 | 1.09 Million AUD | -58.36% |
| 2006 | 2.62 Million AUD | -16.74% |
| 2005 | 3.15 Million AUD | -23.01% |
| 2004 | 4.09 Million AUD | -0.8% |
| 2003 | 4.13 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 18.04 Million AUD | -35.96% |
| 2024 Q4 | 13.42 Million AUD | 0.0% |
| 2024 Q2 | 15.36 Million AUD | 0.0% |
| 2023 FY | 28.17 Million AUD | -36.06% |
| 2023 Q2 | 20.63 Million AUD | 0.0% |
| 2023 Q4 | 28.17 Million AUD | 0.0% |
| 2022 FY | 44.06 Million AUD | 38.24% |
| 2022 Q2 | 34.02 Million AUD | 0.0% |
| 2022 Q4 | 44.06 Million AUD | 0.0% |
| 2021 Q2 | 36.21 Million AUD | 0.0% |
| 2021 Q4 | 31.87 Million AUD | 0.0% |
| 2021 FY | 31.87 Million AUD | -38.13% |
| 2020 Q2 | 42.67 Million AUD | 0.0% |
| 2020 Q4 | 51.51 Million AUD | 0.0% |
| 2020 FY | 51.51 Million AUD | 28.1% |
| 2019 Q4 | 40.21 Million AUD | 0.0% |
| 2019 Q2 | 42.12 Million AUD | 0.0% |
| 2019 FY | 40.21 Million AUD | 41.06% |
| 2018 Q4 | 28.5 Million AUD | 0.0% |
| 2018 Q2 | 22.76 Million AUD | 0.0% |
| 2018 FY | 28.5 Million AUD | 41.38% |
| 2017 FY | 20.16 Million AUD | -9.23% |
| 2017 Q2 | 18.99 Million AUD | 0.0% |
| 2017 Q4 | 20.16 Million AUD | 0.0% |
| 2016 Q4 | 22.21 Million AUD | 0.0% |
| 2016 Q2 | 16.82 Million AUD | 0.0% |
| 2016 FY | 22.21 Million AUD | 298.03% |
| 2015 Q4 | 5.58 Million AUD | 0.0% |
| 2015 FY | 5.58 Million AUD | -17.15% |
| 2015 Q2 | 5.21 Million AUD | 0.0% |
| 2014 Q2 | 5.67 Million AUD | 0.0% |
| 2014 FY | 6.73 Million AUD | 48.04% |
| 2014 Q4 | 6.73 Million AUD | 0.0% |
| 2013 Q4 | 4.51 Million AUD | 0.0% |
| 2013 Q2 | 1.52 Million AUD | 0.0% |
| 2013 FY | 4.55 Million AUD | 53.35% |
| 2012 Q4 | 2.96 Million AUD | 0.0% |
| 2012 FY | 2.96 Million AUD | 31.4% |
| 2011 FY | 2.25 Million AUD | 50.23% |
| 2011 Q4 | 2.25 Million AUD | 0.0% |
| 2010 Q4 | 1.5 Million AUD | 0.0% |
| 2010 FY | 1.5 Million AUD | -4.75% |
| 2009 Q4 | 1.57 Million AUD | 0.0% |
| 2009 FY | 1.57 Million AUD | 13.69% |
| 2008 FY | 1.38 Million AUD | 26.87% |
| 2008 Q4 | 1.38 Million AUD | 0.0% |
| 2007 Q4 | 1.09 Million AUD | 0.0% |
| 2007 FY | 1.09 Million AUD | -58.36% |
| 2006 FY | 2.62 Million AUD | -16.74% |
| 2006 Q4 | 2.62 Million AUD | 0.0% |
| 2005 Q4 | 3.15 Million AUD | 0.0% |
| 2005 FY | 3.15 Million AUD | -23.01% |
| 2004 FY | 4.09 Million AUD | -0.8% |
| 2004 Q4 | 4.09 Million AUD | 0.0% |
| 2003 FY | 4.13 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Althea Group Holdings Limited | 23.33 Million AUD | 42.465% |
| Cann Group Limited | 78.85 Million AUD | 82.971% |
| ECS Botanics Holdings Ltd | 4.66 Million AUD | -187.596% |
| Ecofibre Limited | 30.27 Million AUD | 55.656% |
| Elixinol Wellness Limited | 5.24 Million AUD | -155.801% |
| Hygrovest Limited | 2.68 Million AUD | -400.821% |
| IDT Australia Limited | 7.93 Million AUD | -69.319% |
| Invion Limited | 1.01 Million AUD | -1224.403% |
| Little Green Pharma Ltd | 16.39 Million AUD | 18.085% |
| Live Verdure Ltd | 1.95 Million AUD | -587.044% |
| Vitura Health Limited | 32.83 Million AUD | 59.113% |
| Vita Life Sciences Limited | 16.47 Million AUD | 18.506% |